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In a recent retrospective, cohort, observational study con-
ducted at Division of Internal Medicine of the Holy Family
Hospital, Nazareth, Israel, between April 2013 and April
2015 on patients who underwent screening colonoscopy,
the authors concluded that for the first time an association
between biopsy-proven nonalcoholic steatohepatitis (NASH)
and the burden of hyperplastic polyp (HP) was shown [1].
The same group has published in Israel Medical Association
Journal on the association between nonalcoholic fatty liver
disease (NAFLD) and hyperplastic polyp [2].
Apart from the fact that the authors should explain the
differences between these two publications [1, 2], we would
like to highlight some issues.
In the first part of the paper, Mahamit et al. reported
that other risk factors (compared to lifestyle and dietary risk
factors) for development of HP include alcohol consumption,
cigarette smoking, obesity, metabolic syndrome, and fiber
intake: these are not “other” risk factors but are examples of
lifestyle and dietary risk factors.
Moreover, the authors remind us that metabolic syn-
drome is a risk for HP and nonalcoholic fatty liver disease
(NAFLD). To appropriately assess if NASH is a risk factor in
the development of HP, a control population without NASH
should be chosen. In this study, the control population does
not statistically differ from the cases (biopsy-proven NASH)
in terms of prevalence of metabolic syndrome, diabetes
mellitus, hypertension, and hyperlipidemia, which are NASH
risk factors [3]. Thus, although the authors reported that
the controls were not affected by NASH (whose definitive
diagnosis requires a liver biopsy [4]), more information on
the assessment of liver status is required to minimize the risk
of biases and to establish the real prevalence of HP (i.e., a
familiar history positive for polyps and use of nonsteroidal
anti-inflammatory drugs) in cases and controls [1].
Another criticism arises from the consideration that
not all endoscopists report routinely hyperplastic-appearing
diminutive rectosigmoid polyps. This is supported by the
fact that current colonoscopic practice does not systemati-
cally remove all diminutive rectosigmoid lesions that appear
hyperplastic and supports the “do not resect” paradigm
proposed by the American Society for Gastrointestinal
Endoscopy [5]. Only colonoscopies performed in a study
setting with the endoscopists alerted to report all HP could
give their real prevalence.
In conclusion, prospective studies are required to confirm
if NASH is a risk factor for HP.
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